<DOC>
	<DOCNO>NCT00633243</DOCNO>
	<brief_summary>We hypothesize integrate Hepatitis C methadone buprenorphine treatment improve Hepatitis C outcomes well drug treatment outcomes patient addict opiate . We test hypothesis randomly assign patient receive integrate separated care . The first group receive Hepatitis C treatment substance abuse treatment contemporaneously South Central Rehabilitation Center ( SCRC ) . They take methadone buprenorphine Hepatitis C medication daily ( methadone ) weekly ( buprenorphine ) observation health care provider . The second group receive substance abuse treatment SCRC , go another facility receive Hepatitis C treatment service . These participant take medication ( without observation ) . We look outcomes Hepatitis C viral load , adherence medication , drug treatment outcomes receipt buprenorphine methadone urine toxicology test .</brief_summary>
	<brief_title>Effective Treatment Hepatitis C Substance Users</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<criteria>Subjects DSM IV diagnosis opioid dependence currently enrol methadone buprenorphine maintenance South Central Rehabilitation Center good standing ( opiate free urine positive methadone buprenorphine , respectively ) least 30 day . Hepatitis C infection evidence positive HCV antibody detectable HCV RNA . Suicidal homicidal ideation Psychiatric condition stable Pregnancy ( RBV Class C drug pregnancy ) Pending court case warrant would interrupt treatment Decompensated cirrhosis ( Child 's Class B C ) presence hepatocellular carcinoma HIV+ CD4 &lt; 200 CD4 &gt; 200 VL &gt; 5,000 copies/mL Platelet count &lt; 75,000 /mL Hemoglobin &lt; 10 mg/dL Absolute neutrophil count &lt; 1500 cells/mL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>